PCN149 - COST-EFFECTIVENESS OF BRCA1/2 MUTATION PROFILING TO TARGET OLAPARIB USE IN PATIENTS WITH METASTATIC BREAST CANCER IN JAPAN
Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.232
https://www.valueinhealthjournal.com/article/S1098-3015(18)33532-0/fulltext
Title :
PCN149 - COST-EFFECTIVENESS OF BRCA1/2 MUTATION PROFILING TO TARGET OLAPARIB USE IN PATIENTS WITH METASTATIC BREAST CANCER IN JAPAN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)33532-0&doi=10.1016/j.jval.2018.09.232
First page :
Section Title :
Open access? :
No
Section Order :
1732